ABVC BioPharma, Inc. (ABVC) Social Stream

ABVC BioPharma, Inc. (ABVC): $1.08

0.00 (0.00%)

POWR Rating

Component Grades








Add ABVC to Watchlist
Sign Up

Industry: Biotech




#357 of 360

in industry

ABVC BIOPHARMA INC (ABVC) Price Targets From Analysts

Use the tables below to see what analysts covering ABVC BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-09-16 1 $9.5 $3 $6.25 $1.47 325.17%
2022-12-20 1 $9.5 $9.5 $9.5 $1.47 546.26%
2023-01-18 1 $20.2 $20.2 $20.2 $1.47 1274.15%

Price Target Last Issued September 16, 2022

Over the past 0 secs, ABVC's average upside potential has been 1,352.29%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-18 1 2.02 2.02 2.02 0.765 164.05%
2023-01-18 1 20.20 20.20 20.20 0.765 2540.52%

ABVC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABVC as an investment opportunity.

  • ABVC has a greater number of analysts covering the stock than just about none of of all US stocks.
  • ABVC BIOPHARMA INC's variance in analysts' estimates is lower than 10.7% of all US stocks.
  • ABVC has a higher average analyst price target than 62.24% of Healthcare stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, ABVC BIOPHARMA INC's upside potential (average analyst target price relative to current price) is higher than 288.57% of them.

In the Pharmaceutical Products industry, PCSA, MNPR, and CNSP are the three stocks most similar to ABVC BIOPHARMA INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ABVC? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!